Medline (MDLN) Q2 2026 earnings review
Robust Top-Line Momentum Masked by Fire Losses and a Profitability Downgrade
Medline delivered accelerating double-digit revenue growth in Q2 (+11.6% YoY), driven by aggressive market share gains and new customer implementations. However, the bottom line was highly volatile and heavily distorted by one-offs. Net income plunged 58% largely due to a massive $336 million loss from a distribution center fire in Tracy, California. Conversely, Adjusted EBITDA surged 13.4% to $1.06 billion, but this was artificially inflated by a $243 million net IEEPA tariff refund. Stripping out the noise, underlying profitability is under severe pressure. Despite raising full-year organic sales guidance to 9.0%-10.0%, management slashed its FY26 Adjusted EBITDA outlook to $3.3-$3.4 billion, citing inflationary pressures from the Middle East, quality remediation, and retail softness.
🐂 Bull Case
The company continues to win in the market, securing over 65% of its annual goal for total new customer signings in just the first half of 2026. This is driving consecutive quarters of accelerating double-digit sales growth.
Despite P&L noise, Free Cash Flow jumped 37% YoY in the first half to $920 million. This allowed the company to improve its Net Leverage ratio down to 2.9x, providing solid balance sheet flexibility.
🐻 Bear Case
The $200 million cut to the FY26 Adjusted EBITDA guidance midpoint highlights severe cost-containment issues. Inflationary pressures, operational investments, and retail softness are overpowering the operating leverage expected from 11%+ sales growth.
A $336 million Q2 loss related to the Tracy, California distribution center fire wiped out a significant chunk of statutory net income. While insurance recoveries are expected later, the immediate operational disruption and capital loss are a drag.
⚖️ Verdict: ⚪
Neutral. The relentless ability to take market share and secure prime vendor contracts is highly impressive. However, the significant downward revision to full-year EBITDA guidance reveals that Medline is currently sacrificing margins to fuel that growth amidst a hostile macro environment.
Key Themes
EBITDA Guidance Cut Despite Revenue Upgrade
Reversing trend in profitability expectations. Management lowered the FY26 Adjusted EBITDA guidance by $200 million at the midpoint (now $3.3B-$3.4B), down from $3.5B-$3.6B. This is highly concerning because they simultaneously raised Organic Sales guidance. The disconnect proves that the aggressive new customer implementations are coming at a steep margin cost, exacerbated by macro headwinds.
Supply Chain Solutions Driving Hyper-Growth
Accelerating volume. The Supply Chain Solutions segment posted a massive 16.3% YoY revenue jump to $4.14 billion in Q2. Management noted they have already secured 65% of their annual total new customer signings goal in H1 2026. This validates their strategy of using robust supply chain reliability as a weapon to displace decade-long incumbents.
Tracy Distribution Center Fire
A massive, unexpected shock to the P&L. Medline recorded a $336 million loss in Q2 tied to a fire at its Tracy, California distribution center. While this is calculated 'before expected insurance recoveries,' it represents a severe operational hurdle and a massive near-term capital drain that completely torpedoed statutory net income.
Macro Pressures: Middle East Conflict & Inflation
Management explicitly cited 'higher than expected inflationary pressure from the Middle East conflict' as a primary driver for slashing the annual EBITDA guidance. As noted in the Q1 call, rising oil prices directly impact freight and raw material costs (resins, plastics, nitrile gloves). These delayed costs are now actively compressing H2 margins.
Next-Gen Automation and Tech Investments
Capital expenditures reached $207 million in H1, primarily directed toward distribution center automation and kitting manufacturing facilities. This builds on Q1's disclosed rollout of the 'Empower' AI control tower, 'PickPack Pro', and Symbotic robotics. While these operational investments are currently pressuring the EBITDA outlook, they are essential for reducing labor reliance by up to 50% in future years.
Tariff Volatility Distorts the Quarter
Following the US Supreme Court's February ruling that IEEPA tariffs were unauthorized, Medline recognized a massive $243 million net benefit to Q2 Adjusted EBITDA ($332M COGS reduction offset by $89M in customer repayments). Investors must strip this out to understand true operational run-rates, as the FY26 EBITDA guidance explicitly excludes any further benefit from these refunds.
Other KPIs
Accelerating cash generation. Up 37.1% YoY from $671 million in the first half of 2025. This was driven entirely by an increase in net cash from operating activities ($1.12B vs $879M), which outpaced the steady capex spend of $207 million. Efficient working capital management is offsetting the statutory net income hits.
Stable and improving. Down from 3.1x at the end of Q1 2026 and 4.9x at the end of FY2024. Despite the heavy investments and the facility fire loss, strong underlying cash flow generation has allowed Medline to steadily deleverage its balance sheet.
Up 19.9% YoY, yielding an optical margin of 30.1% (up from 26.8% a year ago). However, this segment absorbed the entirety of the $243 million net IEEPA tariff refund benefit. Without this one-time injection, segment margins would have demonstrated compression similar to the broader corporate profile.
Guidance
Accelerating. Upgraded from the previous outlook of 8.5% - 9.5% (and higher than the 8.0% - 9.0% expectation from Q4 2025). Driven by exceptionally strong existing customer growth and rapid implementation of new customer signings. The guide includes the negative optical impact of $89M in IEEPA tariff customer repayments.
Decelerating/Reversing. Cut from the previous target of $3.5 - $3.6 billion. The $200 million midpoint reduction is highly significant and explicitly excludes the $243 million tariff refund recognized in Q2. Management blames Middle East inflation, operational investments to support the high demand, quality remediation, and softness in retail channels.
Key Questions
Timing of Tracy Fire Insurance Recoveries
You recorded a $336 million loss related to the Tracy, CA distribution center fire. What is the expected timeline for the insurance recoveries, and what percentage of that loss do you anticipate will be fully recouped?
EBITDA Margin Bridge
With the FY26 EBITDA guidance lowered by $200M despite higher sales, could you unpack the exact basis-point headwinds? How much of the margin compression is structural investment versus transient Middle East inflation?
Supply Chain Solutions Profitability
The Supply Chain Solutions segment continues to drive top-line hyper-growth (+16.3%), but margins remain razor-thin at 4.9%. At what point in the contract lifecycle do these massive new prime vendor implementations transition from margin-dilutive to margin-accretive?
Retail Channel Softness
You mentioned 'retail channel softness' as a headwind for the lowered EBITDA guidance. Can you provide more color on which specific product categories or customer demographics are driving this slowdown?